PVCT
PROVECTUS BIOPHARMSstockOTC
EODNov 18, 2026
0.0437USD-0.046%(-0.00)61,190
Loading…
Loading…
18.35M
Healthcare
Biotechnology
HQ
Knoxville, TN, USA
Previous Close
$0.04
Beta
-0.19
52-Week High
$0.08 2026-07-09
52-Week Low
$0.04 2026-11-12
SMA 50
$0.05
SMA 200
$0.06
Avg. Vol 10D
282,693
Avg. Vol 30D
144,336
Avg. Vol 90D
139,850
Relative Vol
0.42
419.91M
389.33M
801,174
0.21%
4.57
74.20%
4,423
4,423
4,423
Apr 11, 2002 · 1-for-300.3003 (reverse)
-4.7M
73.45
PVCT Profile
provectus biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. provectus' investigational oncology drug, pv-10, is an ablative immunotherapy under investigation in solid tumor cancers.
PVCT Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.04 | 2026-11-12 | +2.82% | -4.287 |
| 1M | 0.05 | 2026-10-19 | -10.63% | -1.317 |
| 3M | 0.06 | 2026-08-19 | -24.91% | -0.354 |
| 6M | 0.07 | 2026-05-19 | -33.85% | -0.675 |
| 1Y | 0.07 | 2025-11-19 | -37.35% | -0.190 |
| 2Y | 0.11 | 2024-11-19 | -60.29% | — |
| 5Y | 0.05 | 2021-11-19 | -13.46% | -0.060 |
PVCT Stock Summary
PROVECTUS BIOPHARMS (OTC:PVCT) stock price today is $0.04, and today's volume is 61,190. PVCT is down 0.046% today. The 30 day average volume is 144,336. PVCT market cap is $18.35M with 419.91M shares outstanding.